Accelerated Pubertal Tempo in a 46,XY Aromatase-Deficient Patient

2018 ◽  
Vol 90 (4) ◽  
pp. 275-282 ◽  
Author(s):  
Mariana Costanzo ◽  
José Garcia-Feyling ◽  
Nora Saraco ◽  
Roxana Marino ◽  
Natalia Pérez Garrido ◽  
...  

Background: Aromatase deficiency is a rare autosomal recessive disorder. 46,XY-affected patients often remain undiagnosed until late puberty. Only 2 pediatric cases have been reported. Data on pubertal development in affected males are scarce. Aim: To report the clinical phenotype and hormonal studies of an aromatase-deficient boy during the prepubertal and early pubertal period. Results: The patient was the older brother of a 46,XX girl with aromatase deficiency. Molecular analysis revealed a previously reported homozygous mutation (Arg192Cys) in the CYP19A1 gene. Pubertal onset was at 9.8 years. At 11.3 years of age, signs of rapidly progressive puberty were seen. Laboratory tests revealed normal pubertal basal and GnRH-stimulated gonadotropin levels, normal Sertoli cell markers, and increased testosterone. The prepubertal lumbar spine bone mineral density (BMD) was normal but pubertal bone mineral accrual was incomplete, leading to osteopenia. Conclusion: Estrogen restraint on gonadotropin secretion has been demonstrated in animal and human models. Interestingly, our patient presented with accelerated puberty and apparently normal pituitary gonadal function. These findings suggest that aromatase activity may be required to define pubertal progression in boys. Estrogen deficiency due to aromatase deficiency is responsible for insufficient bone mineral accrual during puberty.

2009 ◽  
Vol 94 (6) ◽  
pp. 2009-2014 ◽  
Author(s):  
Zeina M. Nabhan ◽  
Linda A. DiMeglio ◽  
Rong Qi ◽  
Susan M. Perkins ◽  
Erica A. Eugster

Abstract Background: The optimal route of estrogen replacement in Turner syndrome (TS) is unknown. Objective: The objective of the study was to compare conjugated oral vs. transdermal estrogen (TD E2) on bone accrual, uterine growth, pubertal development, IGF-I, and lipids in girls with TS. Methods: Prepubertal GH-treated girls aged 10 yr or older with TS were eligible. Subjects were randomized to conjugated oral estrogen or TD E2 for 1 yr. Assessments included dual-emission x-ray absorptiometry, pelvic ultrasound, Tanner staging, growth velocity, IGF-I, and lipid profile. Results: Twelve girls (14.0 ± 1.7 yr) were enrolled. TD E2 resulted in a significantly greater change in spine bone density at 12 months compared with conjugated oral estrogen (bone mineral content 9.0 ± 0.9 vs. 5.8 ± 0.9 g, P = 0.04; bone mineral density 0.12 ± 0.01 vs. 0.06 ± 0.01 g/cm2, P = 0.004; Z-score 0.7 ± 0.1 vs. 0.3 ± 0.1, P = 0.03). Greater increases in uterine length (4.13 ± 0.39 vs. 1.98 ± 0.39 cm, P = 0.003) and volume (22.2 ± 4.4 vs. 4.0 ± 4.4 ml, P = 0.02) were also found in the TD vs. the oral group at 1 yr. At study end, 66% of subjects in the TD group had a mature uterus vs. 0% in the oral group. No significant differences in other parameters examined were seen. Conclusion: In girls with TS, TD E2 resulted in faster bone accrual at the spine and increased uterine growth compared with conjugated oral estrogen. This pilot study provides preliminary information for optimizing estrogen replacement in this population.


2018 ◽  
Vol 4 (1) ◽  
pp. 6-11 ◽  
Author(s):  
Thanyawee Puthanakit ◽  
Orasri Wittawatmongkol ◽  
Voraporn Poomlek ◽  
Tavitiya Sudjaritruk ◽  
Chantaphat Brukesawan ◽  
...  

2010 ◽  
Vol 34 (4) ◽  
pp. e86-e91 ◽  
Author(s):  
D. Fintini ◽  
C. Brufani ◽  
A. Grossi ◽  
G. Ubertini ◽  
R. Fiori ◽  
...  

2008 ◽  
Vol 93 (5) ◽  
pp. 1676-1681 ◽  
Author(s):  
N. C. Harvey ◽  
M. K. Javaid ◽  
J. R. Poole ◽  
P. Taylor ◽  
S. M. Robinson ◽  
...  

Abstract Background: We have previously demonstrated that maternal body build and lifestyle factors predict neonatal bone mineral accrual. However, the paternal determinants of neonatal bone mass are not known. In this study we explored the relationship between a father’s bone mass and that of his offspring. Methods: A total of 278 pregnancies (142 male and 136 female neonates) were recruited from the Southampton Women’s Survey, a unique, well-established cohort of women, aged 20–34 yr, who had been assessed before and during pregnancy. The neonates and their fathers underwent whole body dual-x-ray absorptiometry (DXA) within 2 wk of birth using a Lunar DPX (General Electric Corp., Madison, WI) and Hologic Discovery instrument (Hologic Inc., Bedford, MA), respectively; correlation and regression methods were used to explore the parental determinants of neonatal bone mass. Results: After adjusting the paternal DXA indices for father’s age and the neonatal for baby’s gestational age and age at DXA scan, there were highly significant positive associations between baby’s whole body bone area, bone mineral content, and bone mineral density and the corresponding indices in the father (P = 0.003, 0.0002, 0.046, respectively) among female infants. These relationships were independent of maternal height and fat stores. The associations for male infants with paternal DXA indices did not achieve statistical significance. Conclusions: The father’s skeletal size predicts skeletal size more strongly in female than male offspring, independently of the mother’s body build. These data point toward the importance of considering paternal genotype in studies exploring the developmental origins of osteoporotic fracture and raise intriguing mechanistic questions about the gender specificity of influences on intrauterine bone mineral accrual.


Sign in / Sign up

Export Citation Format

Share Document